NOGRADERM

Serial Number 79299987
Registration 6571416
700

Registration Progress

Application Filed
Sep 28, 2020
Under Examination
Approved for Publication
Sep 14, 2021
Published for Opposition
Sep 14, 2021
Registered
Nov 30, 2021

Trademark Image

NOGRADERM

Basic Information

Serial Number
79299987
Registration Number
6571416
Filing Date
September 28, 2020
Registration Date
November 30, 2021
Published for Opposition
September 14, 2021
Drawing Code
5000

Status Summary

Current Status
Active
Status Code
700
Status Date
Nov 30, 2021
Registration
Registered
Classes
005 042

Rights Holder

Nogra Pharma Limited

99
Address
33 Sir John Rogerson's Quay
Dublin 2
IE

Ownership History

Nogra Pharma Limited

Original Applicant
99
IE

Nogra Pharma Limited

Owner at Publication
99
IE

Nogra Pharma Limited

Original Registrant
99
IE

Legal Representation

Attorney
Michael A. Marrero

Application History

25 events
Date Code Type Description
Jun 6, 2022 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB
May 17, 2022 FIMP P FINAL DISPOSITION PROCESSED
May 17, 2022 FICS P FINAL DISPOSITION NOTICE SENT TO IB
Feb 28, 2022 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 30, 2021 R.PR A REGISTERED-PRINCIPAL REGISTER
Sep 14, 2021 PUBO A PUBLISHED FOR OPPOSITION
Sep 14, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 14, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 14, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 26, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 26, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 26, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 10, 2021 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 22, 2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 21, 2021 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 21, 2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 22, 2021 RFNT P REFUSAL PROCESSED BY IB
Mar 4, 2021 RFRR P REFUSAL PROCESSED BY MPU
Mar 4, 2021 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 28, 2021 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 27, 2021 CNRT R NON-FINAL ACTION WRITTEN
Feb 20, 2021 DOCK D ASSIGNED TO EXAMINER
Dec 22, 2020 MAFR O APPLICATION FILING RECEIPT MAILED
Dec 18, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 17, 2020 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of immune-inflammatory mediated dermatological diseases and conditions such as acne, psoriasis, and skin diseases; medicated dermatological preparations; antibiotic dermatological products; dermatological pharmaceutical substances; dermatological pharmaceutical products; medicated gels for dermatological use; medicated creams for dermatological use
First Use Anywhere: 0
First Use in Commerce: 0
Class 042
Research and development for the pharmaceutical industry; pharmaceutical research and development; pharmaceutical products development; consultancy relating to pharmaceutical research and development
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005 042